CRISPR immunity: a case study for justified somatic genetic modification?

Journal of Medical Ethics 48 (2):83-85 (2022)
  Copy   BIBTEX

Abstract

The current SARS-CoV-2 pandemic has killed thousands across the world. SARS-CoV-2 is the latest but surely not the last such global pandemic we will face. The biomedical response to such pandemics includes treatment, vaccination, and so on. In this paper, though, we argue that it is time to consider an additional strategy: the somatic enhancement of human immunity. We argue for this approach and consider bioethics objections we believe can be overcome.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,031

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Infection-acquired versus vaccine-induced immunity against covid-19.Tsvetelina Velikova - 2021 - Central Asian Journal of Medical Hypotheses and Ethics 2 (1):29-35.

Analytics

Added to PP
2021-03-04

Downloads
36 (#457,551)

6 months
8 (#415,703)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Is there a problem with enhancement?Frances M. Kamm - 2005 - American Journal of Bioethics 5 (3):5 – 14.
Cognitive Enhancement: Methods, Ethics, Regulatory Challenges. [REVIEW]Nick Bostrom - 2009 - Science and Engineering Ethics 15 (3):311-341.

Add more references